Research and Markets: European Ultrasound Market - Versatile Ultrasound Systems to Boost Successful Patient Diagnosis in Europe

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/1df5f3/european_ultrasoun) has announced the addition of Frost & Sullivan's new report "European Ultrasound Market - Upper Body Applications" to their offering.

“Enhancing customer interaction will be the key for manufacturers, especially now, when the economy is in a slump”

This Frost & Sullivan research service titled European Ultrasound Market - Upper Body Applications provides a detailed analysis of the impact of the economic recession on the medical imaging sector in Europe, ultrasound clinical utility breakdown and market revenue forecasts. This research service also includes an analysis of the factors driving growth, along with the challenges faced by the industry. In this research, Frost & Sullivan's expert analysts thoroughly examine the following technologies: 3-dimensional (3D) and 4-dimensional (4D) imaging, contrast media and elastography.

Market Overview

Versatile Ultrasound Systems to Boost Successful Patient Diagnosis in Europe

With radiation standards becoming increasingly stringent in European hospitals, ultrasound technology has an edge over radioactive applications with respect to patient safety. Ultrasound is non-radioactive, and manufacturers are trying to enhance its versatility in both primary and secondary diagnosis. Additionally, several medical research universities are collecting data on individual organ physiology and function, paving way for therapeutic ultrasound. Smaller companies are also foraying into organ-specific therapeutic ultrasound solutions due to their non-invasive treatment. "Although the ultrasound market in Europe is saturated and is a replacement market, stable growth is projected in the therapeutic and contrast enhanced ultrasound segment," says the analyst of this research. "While clinical research is becoming more intensive, the research facilities and ultrasound companies are forming associations to accelerate its development." Therapeutic ultrasound procedures are not only non-radioactive but also non-invasive, and have a quicker patient recovery time.

However, the economic downturn has compelled many hospitals to cut costs by either delaying their investments in the purchase of medical equipment or opting for used and refurbished systems. Any savings are used to effectively maintain hospital productivity. "Purchasing used and refurbished systems are a priority for hospitals that have budgetary constraints for new medical equipments," explains the analyst. "Additionally, some hospitals are postponing their equipment purchase to the next fiscal year, further impeding the purchase of new equipment."

Ultrasound manufacturers should emphasise the significance of purchasing latest equipment. They should provide a detailed portfolio of the transitions expected with ultrasound technology and convince hospitals to consider long-term investments. "Enhancing customer interaction will be the key for manufacturers, especially now, when the economy is in a slump," concludes the analyst. "Manufacturers should promote specialised programs that accentuate customer involvement, ensuring customer loyalty in the long term."

Technologies

The following technologies are covered in this research: